Over a decade spent treating and researching substance use disorders taught one researcher that the overdose epidemic is a ...

North Carolina is one of many states receiving funds from a series of national opioid settlements resolving litigation ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...

Adial Pharmaceuticals (ADIL) announced patent number 12,221,654 was issued on February 11, 2025, by the United States Patent and Trademark ...

The percentage of patients receiving medication for opioid use disorder in federally qualified health centers increased from 2017 to 2023.

LICADD has been addressing substance use for nearly 70 years, but that fight is not stopping, nor is it's intensity lessening ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

Veterans who were simultaneously prescribed opioids and benzodiazepines by the Veterans Health Administration (VHA) faced an ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...